首页/数据集/MOESM1 of Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

MOESM1 of Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

Figshare2018-09-07 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/MOESM1_of_Personalized_prescription_of_tyrosine_kinase_inhibitors_in_unresectable_metastatic_cholangiocarcinoma/7056860 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 1: Table S1. Additional table.

应用场景：

创建时间：

2018-09-07

癌症靶向治疗

siRNA基因沉默

Increased α-fetoprotein (AFP) levels have been reported to predict a poor prognosis in hepatocellular carcinoma (HCC). We assessed the mechanism of AFP involvement in the progression of HCC and determ

NIAID Data Ecosystem80

First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials

癌症靶向治疗

药物疗效比较

Purpose A variety of targeted drug were developed and proved effective and safe in clinical trials. Our study aims to compare the efficacies and safety of different targeted drugs in advanced hepatoce

NIAID Data Ecosystem50

Identification of Verrucarin A as a Potent and Selective Steroid Receptor Coactivator-3 Small Molecule Inhibitor

癌症靶向治疗

小分子抑制剂

Members of the steroid receptor coactivator (SRC) family are overexpressed in numerous types of cancers. In particular, steroid receptor coactivator 3 (SRC-3) has been recognized as a critical coactiv

NIAID Data Ecosystem30

Crystal structure of BRAF/MEK1 complex with NST-628 and an active RAF dimer

癌症靶向治疗

RAS信号通路抑制

Crystal structure of BRAF/MEK1 complex with NST-628 and an active RAF dimer Descriptor: 1,2-ETHANEDIOL, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Dual specificity mitogen-activated protein kinase kina

Protein Data Bank Japan2024-07-10 更新60

Genomics to select patients with metastatic breast cancer for targeted therapy (microarray agilent)

癌症靶向治疗

精准医疗基因组学

Cancer progression is driven in part by genomic alterations located in oncogenes or tumor suppressor genes. The genomic characterization of cancers has shown a large interpatient heterogeneity regardi

NIAID Data Ecosystem40

MOESM1 of Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

资源简介：

相关数据集